Stock Information
Krystal Biotech Inc (KRYS)
Ticker Symbol: KRYS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $8,446.59 mil
Piotroski score: 6
PE Ratio: 42.7018
EPS (TTM): 6.8404
Revenue (TTM): $12.84 M
Dividend Yield: N/A%
ROE: 18.69%
Latest News
-
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
Thu, May 7, 2026 8:02 AM
-
Krystal Biotech, Inc. 2026 Q1 - Results - Earnings Call Presentation
Wed, May 6, 2026 7:12 PM
-
Krystal Biotech: A Q1 Earnings Beat With Multiple Catalysts In 2026 And 2027
Wed, May 6, 2026 8:49 AM
-
Krystal Biotech Analysts Boost Their Forecasts Following Upbeat Q1 Results
Tue, May 5, 2026 2:19 PM
-
Citigroup Maintains Buy on Krystal Biotech, Raises Price Target to $378
Tue, May 5, 2026 11:53 AM
-
Evercore ISI Group Maintains Outperform on Krystal Biotech, Raises Price Target to $300
Tue, May 5, 2026 9:55 AM
-
Krystal Biotech, Inc. (KRYS) Q1 2026 Earnings Call Transcript
Mon, May 4, 2026 1:43 PM
-
HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $310 Price Target
Mon, May 4, 2026 12:58 PM
-
Krystal Biotech : First Quarter 2026 Earnings Call
Mon, May 4, 2026 12:25 PM
-
Krystal Biotech (NASDAQ:KRYS) Surges After Q1 Beat as VYJUVEK Revenue Hits $116.4M
Mon, May 4, 2026 12:22 PM
Key Financials
Financial data not available
